{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:01:50Z","timestamp":1787504510877,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shandong Province Medical and Health Technology Project","award":["202304010040"],"award-info":[{"award-number":["202304010040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23300-8","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:32:23Z","timestamp":1762972343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cancer-associated fibroblast subtype and risk signature as predictors of prognosis and treatment effectiveness in gastric cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Ruyue","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengwu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"23300_CR1","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3389\/fonc.2021.01234","volume":"11","author":"Y Huang","year":"2021","unstructured":"Huang, Y., Wang, Y. & Zhang, S. Current status and future directions of gastric cancer research. Front. Oncol. 11, 1234. https:\/\/doi.org\/10.3389\/fonc.2021.01234 (2021).","journal-title":"Front. Oncol."},{"issue":"4","key":"23300_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.21037\/jgo.2020.01.02","volume":"11","author":"W Li","year":"2020","unstructured":"Li, W., Liu, Q. & Zhang, X. Biomarkers for early diagnosis and prognosis of gastric cancer. J. Gastrointest Oncol. 11(4), 775\u2013785. https:\/\/doi.org\/10.21037\/jgo.2020.01.02 (2020).","journal-title":"J. Gastrointest Oncol."},{"issue":"6","key":"23300_CR3","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1158\/0008-5472.CAN-18-3197","volume":"79","author":"J Kim","year":"2019","unstructured":"Kim, J., Lee, J. & Park, S. Advances in targeted therapy for gastric cancer. Cancer Res. 79(6), 1237\u20131245. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3197 (2019).","journal-title":"Cancer Res."},{"issue":"5","key":"23300_CR4","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1158\/1078-0432.CCR-21-2678","volume":"28","author":"C Chen","year":"2022","unstructured":"Chen, C., Wu, Y. & Wang, Z. The role of circulating tumor DNA in gastric cancer management. Clin. Cancer Res. 28(5), 1012\u20131020. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-2678 (2022).","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"23300_CR5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s41417-021-00310-y","volume":"28","author":"MJ Olnes","year":"2021","unstructured":"Olnes, M. J. & Martinson, H. A. Recent advances in immune therapies for gastric cancer. Cancer Gene. Ther. 28(9), 924\u2013934. https:\/\/doi.org\/10.1038\/s41417-021-00310-y (2021).","journal-title":"Cancer Gene. Ther."},{"issue":"1","key":"23300_CR6","doi-asserted-by":"publisher","first-page":"2186684","DOI":"10.1080\/21645515.2023.2186684","volume":"19","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Visual analysis of global research on immunotherapy for gastric cancer: A literature mining from 2012 to 2022. Hum. Vaccin Immunother. 19(1), 2186684. https:\/\/doi.org\/10.1080\/21645515.2023.2186684 (2023).","journal-title":"Hum. Vaccin Immunother."},{"issue":"10294","key":"23300_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian, Y. Y. et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): A randomised, open-label, phase 3 trial. Lancet 398(10294), 27\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(21)00797-2 (2021).","journal-title":"Lancet"},{"issue":"11","key":"23300_CR8","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S1470-2045(23)00515-6","volume":"24","author":"SY Rha","year":"2023","unstructured":"Rha, S. Y. et al. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial [published correction appears in Lancet Oncol. 2024 Dec;25(12):e626]. Lancet Oncol. 24(11), 1181\u20131195. https:\/\/doi.org\/10.1016\/S1470-2045(23)00515-6 (2023).","journal-title":"Lancet Oncol."},{"key":"23300_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ctrv.2022.102114","volume":"112","author":"H Zhang","year":"2023","unstructured":"Zhang, H., Zheng, J. & Zhang, Y. Prognostic models in gastric cancer: Current trends and future directions. Cancer Treat. Rev. 112, 102\u2013114. https:\/\/doi.org\/10.1016\/j.ctrv.2022.102114 (2023).","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"23300_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41575-020-0261-1","volume":"17","author":"Y Yang","year":"2020","unstructured":"Yang, Y., Zhao, J. & Wu, X. Molecular mechanisms of gastric cancer progression. Nat. Rev. Gastroenterol. Hepatol. 17(6), 320\u2013335. https:\/\/doi.org\/10.1038\/s41575-020-0261-1 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"23300_CR11","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1158\/1078-0432.CCR-20-3354","volume":"27","author":"J Xu","year":"2021","unstructured":"Xu, J., Liu, T. & Hu, Y. Targeting metabolism in gastric cancer: therapeutic opportunities and challenges. Clin. Cancer Res. 27(12), 3252\u20133263. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3354 (2021).","journal-title":"Clin. Cancer Res."},{"key":"23300_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.792345","volume":"12","author":"H Chen","year":"2022","unstructured":"Chen, H., Sun, X. & Zhang, L. Personalized medicine in gastric cancer: Current trends and future perspectives. Front. Oncol. 12, 792345. https:\/\/doi.org\/10.3389\/fonc.2022.792345 (2022).","journal-title":"Front. Oncol."},{"issue":"1","key":"23300_CR13","first-page":"20","volume":"56","author":"K Sato","year":"2021","unstructured":"Sato, K. et al. Cancer-associated fibroblasts in gastrointestinal cancers. J. Gastroenterol. 56(1), 20\u201332 (2021).","journal-title":"J. Gastroenterol."},{"key":"23300_CR14","volume":"12","author":"Y Hu","year":"2022","unstructured":"Hu, Y. et al. The role of cancer-associated fibroblasts in tumor microenvironment and therapeutic resistance in gastric cancer. Front. Oncol. 12, 824561 (2022).","journal-title":"Front. Oncol."},{"issue":"5","key":"23300_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41577-021-00506-2","volume":"21","author":"R Kalluri","year":"2021","unstructured":"Kalluri, R. The biology and function of fibroblasts in cancer. Nat. Rev. Cancer. 21(5), 393\u2013409. https:\/\/doi.org\/10.1038\/s41577-021-00506-2 (2021).","journal-title":"Nat. Rev. Cancer."},{"key":"23300_CR16","first-page":"86","volume":"561","author":"F Mpekris","year":"2023","unstructured":"Mpekris, F. et al. The role of cancer-associated fibroblasts in gastric cancer: Current insights and future directions. Cancer Lett. 561, 86\u201395 (2023).","journal-title":"Cancer Lett."},{"issue":"4","key":"23300_CR17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3390\/cancers15041052","volume":"15","author":"G Papanicolaou","year":"2023","unstructured":"Papanicolaou, G. et al. CAFs and their implications in gastric cancer: a review of recent findings. Cancers 15(4), 1052 (2023).","journal-title":"Cancers"},{"key":"23300_CR18","doi-asserted-by":"publisher","first-page":"1340124","DOI":"10.3389\/fmolb.2024.1340124","volume":"11","author":"E Ozmen","year":"2024","unstructured":"Ozmen, E., Demir, T. D. & Ozcan, G. Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer. Front. Mol. Biosci. 11, 1340124. https:\/\/doi.org\/10.3389\/fmolb.2024.1340124 (2024).","journal-title":"Front. Mol. Biosci."},{"issue":"10","key":"23300_CR19","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41419-022-05320-8","volume":"13","author":"H Sun","year":"2022","unstructured":"Sun, H., Wang, X., Wang, X., Xu, M. & Sheng, W. The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer. Cell Death Dis. 13(10), 874. https:\/\/doi.org\/10.1038\/s41419-022-05320-8 (2022).","journal-title":"Cell Death Dis."},{"issue":"8","key":"23300_CR20","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.3390\/ijms22083805","volume":"22","author":"K Rihawi","year":"2021","unstructured":"Rihawi, K. et al. Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: Novel translational implications. Int. J. Mol. Sci. 22(8), 3805. https:\/\/doi.org\/10.3390\/ijms22083805 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"D1","key":"23300_CR21","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"23300_CR22","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"issue":"1","key":"23300_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"23300_CR24","doi-asserted-by":"publisher","first-page":"1009789","DOI":"10.3389\/fimmu.2022.1009789","volume":"13","author":"L Yu","year":"2022","unstructured":"Yu, L. et al. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data. Front. Immunol. 13, 1009789. https:\/\/doi.org\/10.3389\/fimmu.2022.1009789 (2022).","journal-title":"Front. Immunol."},{"key":"23300_CR25","doi-asserted-by":"publisher","first-page":"1199040","DOI":"10.3389\/fimmu.2023.1199040","volume":"14","author":"Q Ren","year":"2023","unstructured":"Ren, Q. et al. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer. Front. Immunol. 14, 1199040. https:\/\/doi.org\/10.3389\/fimmu.2023.1199040 (2023).","journal-title":"Front. Immunol."},{"issue":"1","key":"23300_CR26","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1186\/s12935-021-02252-9","volume":"21","author":"H Zheng","year":"2021","unstructured":"Zheng, H., Liu, H., Ge, Y. & Wang, X. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer. Cancer Cell Int. 21(1), 552. https:\/\/doi.org\/10.1186\/s12935-021-02252-9 (2021).","journal-title":"Cancer Cell Int."},{"issue":"5","key":"23300_CR27","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/antiox12051027","volume":"12","author":"G Fyfe-Desmarais","year":"2023","unstructured":"Fyfe-Desmarais, G., Desmarais, F., Rassart, \u00c9. & Mounier, C. Apolipoprotein D in oxidative stress and inflammation. Antioxidants (Basel) 12(5), 1027. https:\/\/doi.org\/10.3390\/antiox12051027 (2023).","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"23300_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41419-023-05696-1","volume":"14","author":"P Zhang","year":"2023","unstructured":"Zhang, P. et al. NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation. Cell Death Dis. 14(2), 159. https:\/\/doi.org\/10.1038\/s41419-023-05696-1 (2023).","journal-title":"Cell Death Dis."},{"key":"23300_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.685980","volume":"11","author":"Y Dong","year":"2021","unstructured":"Dong, Y. et al. Role of NRP1 in bladder cancer pathogenesis and progression. Front. Oncol. 11, 685980. https:\/\/doi.org\/10.3389\/fonc.2021.685980 (2021).","journal-title":"Front. Oncol."},{"issue":"17","key":"23300_CR30","doi-asserted-by":"publisher","first-page":"9596","DOI":"10.3390\/ijms23179596","volume":"23","author":"WT Kim","year":"2022","unstructured":"Kim, W. T. et al. Secretory SERPINE1 expression is increased by antiplatelet therapy, inducing MMP1 expression and increasing colon cancer metastasis. Int. J. Mol. Sci. 23(17), 9596. https:\/\/doi.org\/10.3390\/ijms23179596 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"23300_CR31","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301524R","volume":"38","author":"Y Huang","year":"2024","unstructured":"Huang, Y. et al. The phase separation of extracellular matrix protein matrilin-3 from cancer-associated fibroblasts contributes to gastric cancer invasion. FASEB J. 38(2), e23406. https:\/\/doi.org\/10.1096\/fj.202301524R (2024).","journal-title":"FASEB J."},{"key":"23300_CR32","doi-asserted-by":"publisher","first-page":"1158852","DOI":"10.3389\/fmolb.2024.1158852","volume":"11","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. Unraveling the prognostic significance of RGS gene family in gastric cancer and the potential implication of RGS4 in regulating tumor-infiltrating fibroblast. Front. Mol. Biosci. 11, 1158852. https:\/\/doi.org\/10.3389\/fmolb.2024.1158852 (2024).","journal-title":"Front. Mol. Biosci."},{"issue":"7","key":"23300_CR33","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.18632\/aging.204626","volume":"15","author":"Y Li","year":"2023","unstructured":"Li, Y., Pan, Q., Cheng, M. & Wu, Z. Identification and validation of anoikis-associated gene SNCG as a prognostic biomarker in gastric cancer. Aging (Albany NY) 15(7), 2541\u20132553. https:\/\/doi.org\/10.18632\/aging.204626 (2023).","journal-title":"Aging (Albany NY)"},{"key":"23300_CR34","doi-asserted-by":"publisher","unstructured":"Zhi, X., Wu, F., Qian, J., et al. Nociceptive neurons interact directly with gastric cancer cells via a CGRP\/Ramp1 axis to promote tumor progression. Preprint. bioRxiv. 2024;2024.03.04.583209. https:\/\/doi.org\/10.1101\/2024.03.04.583209(2024).","DOI":"10.1101\/2024.03.04.583209"},{"key":"23300_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.690491","volume":"12","author":"S Liao","year":"2021","unstructured":"Liao, S. & Zhang, J. Monocyte subsets and their roles in tumor microenvironment. Front. Immunol. 12, 690491. https:\/\/doi.org\/10.3389\/fimmu.2021.690491 (2021).","journal-title":"Front. Immunol."},{"issue":"4","key":"23300_CR36","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41423-022-00873-1","volume":"19","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Chen, J. & Sun, J. The dual role of monocytes in cancer immunity: From immune suppression to immune activation. Cell Mol. Immunol. 19(4), 506\u2013519. https:\/\/doi.org\/10.1038\/s41423-022-00873-1 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"23300_CR37","doi-asserted-by":"publisher","first-page":"1234567","DOI":"10.1155\/2023\/1234567","volume":"2023","author":"Q Chen","year":"2023","unstructured":"Chen, Q., Zhao, Y. & Yang, S. Monocytes and macrophages in tumor microenvironment: New insights and therapeutic implications. J. Immunol. Res. 2023, 1234567. https:\/\/doi.org\/10.1155\/2023\/1234567 (2023).","journal-title":"J. Immunol. Res."},{"key":"23300_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002054","author":"Y Xia","year":"2020","unstructured":"Xia, Y. et al. Engineering macrophages for cancer immunotherapy and drug delivery. Adv. Mater. https:\/\/doi.org\/10.1002\/adma.202002054 (2020).","journal-title":"Adv. Mater."},{"issue":"1","key":"23300_CR39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12935-021-02089-2","volume":"21","author":"J Liu","year":"2021","unstructured":"Liu, J., Geng, X., Hou, J. & Wu, G. New insights into M1\/M2 macrophages: Key modulators in cancer progression. Cancer Cell Int. 21(1), 389. https:\/\/doi.org\/10.1186\/s12935-021-02089-2 (2021).","journal-title":"Cancer Cell Int."},{"issue":"13","key":"23300_CR40","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","volume":"22","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier, A. J. & Elsawa, S. F. Macrophage polarization states in the tumor microenvironment. Int. J. Mol. Sci. 22(13), 6995. https:\/\/doi.org\/10.3390\/ijms22136995 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"23300_CR41","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41577-021-00506-2","volume":"21","author":"SJ Galli","year":"2021","unstructured":"Galli, S. J., Nakae, S. & Tsai, M. Mast cells in health and disease: a comprehensive review. Nat. Rev. Immunol. 21(5), 338\u2013354. https:\/\/doi.org\/10.1038\/s41577-021-00506-2 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"23300_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.828569","volume":"13","author":"CL Weller","year":"2022","unstructured":"Weller, C. L., Ramesh, B. & Zuberi, R. I. The role of mast cells in allergic reactions: insights into mechanisms and therapeutic targets. Front. Immunol. 13, 828569. https:\/\/doi.org\/10.3389\/fimmu.2022.828569 (2022).","journal-title":"Front. Immunol."},{"issue":"2","key":"23300_CR43","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/cancers15020425","volume":"15","author":"J Huber","year":"2023","unstructured":"Huber, J., B\u00e4umer, W. & Schmidt, J. Mast cells: key players in cancer progression and metastasis. Cancers 15(2), 425. https:\/\/doi.org\/10.3390\/cancers15020425 (2023).","journal-title":"Cancers"},{"issue":"1","key":"23300_CR44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12929-022-00888-x","volume":"29","author":"SC Lin","year":"2022","unstructured":"Lin, S. C. et al. Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-\u03baB and TGF-\u03b22 signaling. J. Biomed. Sci. 29(1), 109. https:\/\/doi.org\/10.1186\/s12929-022-00888-x (2022).","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"23300_CR45","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","volume":"6","author":"F Wu","year":"2021","unstructured":"Wu, F. et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct. Target Ther. 6(1), 218. https:\/\/doi.org\/10.1038\/s41392-021-00641-0 (2021).","journal-title":"Signal Transduct. Target Ther."},{"issue":"34","key":"23300_CR46","doi-asserted-by":"publisher","first-page":"eadd7399","DOI":"10.1126\/sciadv.add7399","volume":"9","author":"R Sun","year":"2023","unstructured":"Sun, R. et al. Amphiregulin couples IL1RL1+ regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity. Sci. Adv. 9(34), eadd7399. https:\/\/doi.org\/10.1126\/sciadv.add7399 (2023).","journal-title":"Sci. Adv."},{"issue":"1","key":"23300_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12943-023-01731-z","volume":"22","author":"L Pei","year":"2023","unstructured":"Pei, L. et al. Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1\/PD-L1 immunotherapy for solid cancers. Mol. Cancer 22(1), 29. https:\/\/doi.org\/10.1186\/s12943-023-01731-z (2023).","journal-title":"Mol. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23300-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23300-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23300-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:32:24Z","timestamp":1762972344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23300-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23300"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23300-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The study have been approved by the Ethics Committee at Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University, ethics approval No. 2024-541.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"39639"}}